Complete Filing Data
Trevi Therapeutics, Inc. reported Stockholders Equity of $183.24 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Trevi Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$42.8M | -$47.9M | -$29.1M | -$29.2M | -$33.9M | -$32.8M | -$26.1M | -$20.5M |
| Research And Development Expense | $33.5M | $39.4M | $23.7M | $19.8M | $23.0M | $22.3M | $19.3M | $14.1M |
| Operating Income Loss | -$49.3M | -$51.5M | -$33.9M | -$29.9M | -$32.5M | -$32.5M | -$26.6M | -$18.4M |
| Operating Expenses | $49.3M | $51.5M | $33.9M | $29.9M | $32.5M | $32.5M | $26.6M | $18.4M |
| Nonoperating Income Expense | $6.5M | $3.6M | $4.8M | $719.0K | -$1.5M | -$287.0K | $577.0K | -$2.3M |
| Income Tax Expense Benefit | -$64.0K | -$30.0K | -$32.0K | -$36.0K | -$21.0K | -$18.0K | -$18.0K | -$124.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$42.8M | -$47.9M | -$29.1M | -$29.2M | -$34.0M | -$32.8M | -$26.1M | -$20.7M |
| General And Administrative Expense | $15.9M | $12.1M | $10.2M | $10.1M | $9.5M | $10.2M | $7.3M | $4.3M |
| Interest Income Expense Nonoperating Net | $4.7M | $1.7M | $10.0K | $178.0K | $792.0K | $156.0K | ||
| Interest Expense | $391.0K | $1.2M | $1.2M | $456.0K | $174.0K | |||
| Comprehensive Income Net Of Tax | -$42.7M | -$47.8M | -$29.0M | -$29.3M | -$33.9M | |||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $87.0K | $90.0K | $93.0K | -$122.0K | ||||
| Other Nonoperating Income Expense | -$31.0K | -$15.0K | $469.0K | $289.0K | -$375.0K | |||
| Net Income Loss Available To Common Stockholders Basic | -$32.8M | -$26.8M | -$25.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$11.8M | -$12.3M | -$10.3M | -$13.2M | -$12.4M | -$10.9M | -$7.7M | -$7.1M | -$6.4M | -$8.3M | -$8.1M | -$7.3M | -$7.3M | -$9.8M | -$8.4M | -$7.4M | -$7.4M | -$8.5M | -$7.4M | -$7.3M | -$4.8M | -$5.7M | -$4.9M | -$4.1M |
| Research And Development Expense | $10.1M | $9.4M | $7.8M | $11.2M | $10.0M | $8.8M | $6.3M | $5.8M | $5.0M | $5.8M | $5.1M | $4.6M | $4.7M | $6.5M | $5.6M | $4.8M | $4.9M | $6.0M | $5.7M | $5.5M | $3.3M | $3.7M | $3.4M | $2.4M |
| Operating Income Loss | -$13.9M | -$13.7M | -$11.5M | -$14.1M | -$13.3M | -$11.9M | -$9.0M | -$8.4M | -$7.6M | -$8.4M | -$7.8M | -$7.0M | -$6.9M | -$9.2M | -$8.1M | -$7.2M | -$7.4M | -$8.6M | -$7.7M | -$7.4M | -$4.8M | -$5.0M | -$4.4M | -$3.1M |
| Operating Expenses | $13.9M | $13.7M | $11.5M | $14.1M | $13.3M | $11.9M | $9.0M | $8.4M | $7.6M | $8.4M | $7.8M | $7.0M | $6.9M | $9.2M | $8.1M | $7.2M | $7.4M | $8.6M | $7.7M | $7.4M | $4.8M | $5.0M | $4.4M | $3.1M |
| Nonoperating Income Expense | $2.1M | $1.4M | $1.1M | $814.0K | $929.0K | $996.0K | $1.3M | $1.2M | $1.2M | $132.0K | -$236.0K | -$309.0K | -$306.0K | -$629.0K | -$297.0K | -$145.0K | $14.0K | $157.0K | $280.0K | $66.0K | $6.0K | -$722.0K | -$503.0K | -$934.0K |
| Income Tax Expense Benefit | -$15.0K | -$21.0K | -$11.0K | -$31.0K | -$8.0K | -$8.0K | -$13.0K | -$30.0K | -$7.0K | -$7.0K | -$4.0K | -$5.0K | $2.0K | -$2.0K | -$15.0K | -$11.0K | -$15.0K | -$9.0K | -$5.0K | -$5.0K | -$4.0K | -$25.0K | -$25.0K | -$25.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$11.8M | -$12.3M | -$10.4M | -$13.3M | -$12.4M | -$10.9M | -$7.7M | -$7.2M | -$6.4M | -$8.3M | -$8.1M | -$7.3M | -$7.3M | -$9.8M | -$8.4M | -$7.4M | -$7.4M | -$8.5M | -$7.4M | -$7.4M | -$4.8M | -$5.7M | -$4.9M | -$4.1M |
| General And Administrative Expense | $3.8M | $4.3M | $3.7M | $2.9M | $3.3M | $3.1M | $2.7M | $2.5M | $2.6M | $2.6M | $2.7M | $2.4M | $2.2M | $2.7M | $2.5M | $2.4M | $2.5M | $2.6M | $2.0M | $1.9M | $1.5M | $1.2M | $941.0K | $779.0K |
| Interest Income Expense Nonoperating Net | $935.0K | $998.0K | $1.2M | $1.2M | $1.2M | $424.0K | $195.0K | $4.0K | $2.0K | $2.0K | $3.0K | $3.0K | $14.0K | $157.0K | $280.0K | $229.0K | $58.0K | $27.0K | $38.0K | $45.0K | ||||
| Interest Expense | $1.0K | $1.0K | $3.0K | $153.0K | $231.0K | $292.0K | $295.0K | $302.0K | $303.0K | $296.0K | $294.0K | $148.0K | $51.0K | $123.0K | ||||||||||
| Comprehensive Income Net Of Tax | -$11.8M | -$12.4M | -$10.3M | -$13.0M | -$12.4M | -$10.9M | -$7.7M | -$7.3M | -$6.4M | -$8.4M | -$8.2M | -$7.3M | -$7.3M | -$9.8M | ||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $6.0K | -$49.0K | $12.0K | $223.0K | -$17.0K | -$38.0K | $31.0K | -$160.0K | $34.0K | -$128.0K | $135.0K | |||||||||||||
| Other Nonoperating Income Expense | -$2.0K | -$7.0K | -$6.0K | -$11.0K | -$5.0K | -$1.0K | $154.0K | $153.0K | $165.0K | |||||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$7.4M | -$7.4M | -$8.5M | -$7.4M | -$6.7M | -$6.2M | -$7.1M | -$6.0M | -$5.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $183.2M | $99.6M | $82.5M | $107.5M | $17.1M | $27.3M | $54.5M | -$109.5M | -$84.4M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $18.9M | $34.1M | $32.4M | $12.6M | $36.8M | $45.0M | $57.3M | $7.2M | $22.0M |
| Cash And Cash Equivalents At Carrying Value | $18.9M | $34.1M | $32.4M | $12.6M | $36.8M | $45.0M | $57.3M | $7.2M | |
| Retained Earnings Accumulated Deficit | -$329.8M | -$287.0M | -$239.1M | -$210.1M | -$180.9M | -$147.0M | -$114.2M | -$109.5M | |
| Property Plant And Equipment Net | $178.0K | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K | |
| Liabilities Current | $9.7M | $10.5M | $5.8M | $13.4M | $12.7M | $5.6M | $5.2M | $2.7M | |
| Liabilities And Stockholders Equity | $193.4M | $110.9M | $89.4M | $123.0M | $38.5M | $47.1M | $60.0M | $10.5M | |
| Common Stock Value | $128.0K | $94.0K | $68.0K | $60.0K | $29.0K | $19.0K | $18.0K | $4.0K | |
| Assets Current | $191.7M | $109.4M | $87.5M | $122.6M | $38.0M | $46.3M | $59.6M | $8.8M | |
| Assets | $193.4M | $110.9M | $89.4M | $123.0M | $38.5M | $47.1M | $60.0M | $10.5M | |
| Accrued Liabilities Current | $5.5M | $6.8M | $3.7M | $3.5M | $3.8M | $3.4M | $3.5M | $2.1M | |
| Accounts Payable Current | $3.9M | $3.4M | $1.8M | $2.9M | $2.8M | $2.0M | $1.6M | $603.0K | |
| Operating Lease Right Of Use Asset | $677.0K | $915.0K | $1.1M | $24.0K | $131.0K | $227.0K | $312.0K | $379.0K | |
| Operating Lease Liability Noncurrent | $446.0K | $747.0K | $1.0M | $2.0K | $24.0K | $144.0K | $257.0K | $46.0K | |
| Operating Lease Liability Current | $307.0K | $254.0K | $184.0K | $25.0K | $120.0K | $113.0K | $99.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$15.2M | $1.7M | $19.8M | -$24.2M | -$8.2M | -$12.3M | $50.1M | -$14.8M | |
| Liabilities | $10.2M | $11.3M | $6.9M | $15.6M | $21.4M | $19.8M | |||
| Other Assets Noncurrent | $928.0K | $243.0K | $297.0K | $205.0K | $334.0K | $532.0K | |||
| Other Assets Current | $2.1M | $867.0K | $955.0K | $1.3M | $241.0K | $265.0K | |||
| Finance Lease Principal Payments | $11.0K | $126.0K | $95.0K | ||||||
| Marketable Securities Current | $169.3M | $73.5M | $50.6M | $107.9M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $148.0K | $61.0K | -$29.0K | -$122.0K | |||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.6M | $1.4M | $2.1M | $829.0K | |||||
| Long Term Loans Payable | $2.2M | $8.7M | $14.0M | ||||||
| Operating Lease Right Of Use Asset Amortization Expense | $437.0K | $460.0K | $377.0K | $0.00 | |||||
| Finance Lease Right Of Use Asset | $0.00 | $157.0K | $206.0K | ||||||
| Finance Lease Liability Current | $0.00 | $31.0K | $122.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $189.8M | $198.5M | $99.5M | $59.0M | $66.2M | $72.3M | $89.6M | $95.1M | $101.7M | $109.9M | $60.5M | $10.5M | $11.4M | $17.7M | $23.7M | $35.6M | $40.0M | $46.8M | $60.7M | $67.7M | -$115.5M | -$102.3M | -$95.3M | -$89.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $56.9M | $117.1M | $19.4M | $16.1M | $13.0M | $13.8M | $26.0M | $13.8M | $11.7M | $66.6M | $24.7M | $29.1M | $29.3M | $36.4M | $41.6M | $53.3M | $44.2M | $52.6M | $63.5M | $71.4M | $12.9M | ||||
| Cash And Cash Equivalents At Carrying Value | $56.9M | $117.1M | $19.4M | $16.1M | $13.0M | $13.8M | $26.0M | $13.8M | $11.7M | $66.6M | $24.7M | $29.1M | $29.3M | $36.4M | $41.6M | $53.3M | $44.2M | $52.6M | $63.5M | $71.4M | $12.9M | $13.5M | $7.1M | $16.0M | $22.0M |
| Retained Earnings Accumulated Deficit | -$321.5M | -$309.7M | -$297.4M | -$275.6M | -$262.4M | -$250.0M | -$231.3M | -$223.6M | -$216.5M | -$204.6M | -$196.3M | -$188.2M | -$172.4M | -$165.1M | -$155.3M | -$137.5M | -$130.1M | -$122.7M | -$107.7M | -$100.3M | -$115.5M | ||||
| Property Plant And Equipment Net | $213.0K | $239.0K | $277.0K | $174.0K | $198.0K | $204.0K | $238.0K | $225.0K | $245.0K | $68.0K | $34.0K | $42.0K | $66.0K | $78.0K | $91.0K | $110.0K | $109.0K | $107.0K | $128.0K | $139.0K | $149.0K | ||||
| Liabilities Current | $9.0M | $9.2M | $6.9M | $9.1M | $6.8M | $5.3M | $5.2M | $4.7M | $13.2M | $14.6M | $15.4M | $12.9M | $9.9M | $9.4M | $5.3M | $6.1M | $6.8M | $7.2M | $5.0M | $7.1M | $3.7M | ||||
| Liabilities And Stockholders Equity | $199.4M | $208.3M | $107.0M | $68.9M | $73.8M | $78.6M | $95.9M | $101.0M | $116.2M | $128.4M | $81.4M | $30.4M | $31.6M | $39.1M | $42.9M | $55.9M | $47.0M | $54.2M | $66.0M | $75.1M | $17.2M | ||||
| Common Stock Value | $128.0K | $122.0K | $100.0K | $75.0K | $73.0K | $69.0K | $64.0K | $63.0K | $60.0K | $58.0K | $40.0K | $31.0K | $22.0K | $21.0K | $20.0K | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $4.0K | ||||
| Assets Current | $198.3M | $207.2M | $105.6M | $67.3M | $72.1M | $76.8M | $94.0M | $99.2M | $114.2M | $127.3M | $79.9M | $29.8M | $30.7M | $38.5M | $42.2M | $55.2M | $46.3M | $53.8M | $65.5M | $74.6M | $14.8M | ||||
| Assets | $199.4M | $208.3M | $107.0M | $68.9M | $73.8M | $78.6M | $95.9M | $101.0M | $116.2M | $128.4M | $81.4M | $30.4M | $31.6M | $39.1M | $42.9M | $55.9M | $47.0M | $54.2M | $66.0M | $75.1M | $17.2M | ||||
| Accrued Liabilities Current | $6.0M | $6.0M | $5.2M | $7.2M | $4.9M | $2.8M | $3.6M | $3.1M | $3.5M | $5.2M | $4.4M | $3.9M | $3.3M | $3.3M | $3.8M | $4.7M | $3.5M | $4.9M | $4.4M | $4.4M | $3.1M | ||||
| Accounts Payable Current | $2.7M | $3.0M | $1.4M | $1.6M | $1.5M | $2.1M | $1.3M | $1.4M | $2.0M | $2.3M | $3.9M | $1.7M | $2.2M | $3.5M | $801.0K | $1.3M | $3.2M | $2.2M | $489.0K | $2.7M | $498.0K | ||||
| Operating Lease Right Of Use Asset | $741.0K | $804.0K | $865.0K | $973.0K | $1.0M | $1.1M | $1.2M | $1.2M | $1.3M | $53.0K | $82.0K | $107.0K | $156.0K | $181.0K | $204.0K | $250.0K | $271.0K | $292.0K | $331.0K | $350.0K | $368.0K | ||||
| Operating Lease Liability Noncurrent | $527.0K | $605.0K | $681.0K | $816.0K | $884.0K | $949.0K | $1.1M | $1.1M | $1.1M | $2.0K | $3.0K | $58.0K | $91.0K | $123.0K | $173.0K | $202.0K | $230.0K | $283.0K | $308.0K | $333.0K | |||||
| Operating Lease Liability Current | $296.0K | $286.0K | $276.0K | $235.0K | $216.0K | $198.0K | $171.0K | $157.0K | $144.0K | $59.0K | $92.0K | $123.0K | $116.0K | $111.0K | $107.0K | $110.0K | $106.0K | $102.0K | $95.0K | $91.0K | $88.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$14.7M | -$18.6M | -$938.0K | -$7.7M | -$3.4M | -$4.7M | $5.7M | ||||||||||||||||||
| Liabilities | $9.6M | $9.8M | $7.5M | $9.9M | $7.6M | $6.2M | $6.3M | $5.9M | $14.5M | $18.5M | $20.9M | $19.9M | $20.2M | $21.4M | $19.2M | ||||||||||
| Other Assets Noncurrent | $103.0K | $68.0K | $241.0K | $256.0K | $273.0K | $311.0K | $297.0K | $68.0K | $225.0K | $922.0K | $413.0K | $398.0K | |||||||||||||
| Other Assets Current | $2.0M | $1.6M | $834.0K | $667.0K | $830.0K | $721.0K | $1.0M | $2.1M | $1.6M | $421.0K | $382.0K | $249.0K | |||||||||||||
| Finance Lease Principal Payments | $0.00 | $0.00 | $11.0K | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | |||||||||||||||||
| Marketable Securities Current | $138.1M | $86.8M | $83.9M | $49.4M | $56.5M | $59.0M | $62.9M | $80.4M | $99.6M | $59.0M | $53.2M | ||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $30.0K | $24.0K | $73.0K | $139.0K | -$84.0K | -$67.0K | -$217.0K | -$248.0K | -$88.0K | -$263.0K | -$135.0K | ||||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $395.0K | $381.0K | $671.0K | ||||||||||||||||||||||
| Long Term Loans Payable | $3.8M | $5.4M | $7.1M | $10.2M | $11.9M | $13.5M | $13.8M | ||||||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $112.0K | $120.0K | |||||||||||||||||||||||
| Finance Lease Right Of Use Asset | $0.00 | $0.00 | $169.0K | $181.0K | $194.0K | $218.0K | $230.0K | $242.0K | |||||||||||||||||
| Finance Lease Liability Current | $0.00 | $0.00 | $62.0K | $93.0K | $124.0K | $121.0K | $120.0K | $118.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $5.2M | $3.6M | $2.2M | $2.3M | $2.5M | $2.4M | $1.1M | $496.0K |
| Net Cash Provided By Used In Operating Activities | -$42.1M | -$38.3M | -$31.7M | -$28.2M | -$28.9M | -$29.0M | -$23.1M | -$18.3M |
| Increase Decrease In Accrued Liabilities | -$1.4M | $2.6M | $52.0K | -$639.0K | $336.0K | -$101.0K | $1.4M | $772.0K |
| Increase Decrease In Accounts Payable | -$598.0K | $1.6M | -$1.0M | $9.0K | $831.0K | $417.0K | $777.0K | $66.0K |
| Net Cash Provided By Used In Financing Activities | $121.0M | $61.5M | -$7.9M | $111.3M | $20.8M | $16.7M | $73.2M | $3.6M |
| Payments Of Stock Issuance Costs | $809.0K | $258.0K | $226.0K | $382.0K | $377.0K | $1.2M | $1.5M | |
| Net Cash Provided By Used In Investing Activities | -$94.1M | -$21.5M | $59.4M | -$107.4M | -$32.0K | -$9.0K | -$158.0K | |
| Proceeds From Stock Options Exercised | $2.1M | $394.0K | $74.0K | $139.0K | $34.0K | $38.0K | $13.0K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.5M | -$2.7M | $2.9M | $601.0K | -$342.0K | -$742.0K | ||
| Payments To Acquire Property Plant And Equipment | $12.0K | $35.0K | $137.0K | $159.0K | $32.0K | $9.0K | $158.0K | |
| Proceeds From Stock Plans | $118.0K | $70.0K | $68.0K | $56.0K | $39.0K | $12.0K | ||
| Payments To Acquire Marketable Securities | $170.7M | $98.5M | $9.9M | $126.2M | ||||
| Depreciation Depletion And Amortization | $144.0K | $147.0K | $123.0K | $43.0K | ||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $76.6M | $77.0M | $69.5M | $19.0M | ||||
| Proceeds From At Market Sales Net Of Commissions | $14.1M | $1.7M | $7.5M | $3.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $1.2M | $1.4M | $1.2M | $822.0K | $1.1M | $723.0K | $530.0K | $530.0K | $578.0K | $569.0K | $520.0K | $737.0K | $540.0K | $745.0K | $718.0K | $588.0K | $589.0K | $730.0K | $371.0K | $237.0K | $146.0K | $121.0K | $102.0K | $88.0K |
| Net Cash Provided By Used In Operating Activities | -$13.5M | -$10.5M | -$8.2M | -$7.1M | -$7.6M | -$4.7M | -$4.1M | -$4.0M | ||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$1.5M | -$940.0K | -$63.0K | $14.0K | $447.0K | $1.4M | $880.0K | -$799.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable | -$2.0M | $294.0K | -$914.0K | -$1.1M | -$1.2M | $594.0K | -$185.0K | $109.0K | ||||||||||||||||
| Net Cash Provided By Used In Financing Activities | $8.7M | -$28.0K | -$1.7M | -$625.0K | $4.1M | $9.8M | -$2.1M | |||||||||||||||||
| Payments Of Stock Issuance Costs | $222.0K | $15.0K | $44.0K | $31.0K | ||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$10.0M | -$8.1M | $9.0M | -$9.0K | -$57.0K | |||||||||||||||||||
| Proceeds From Stock Options Exercised | $718.0K | $4.0K | $62.0K | $24.0K | $13.0K | |||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $605.0K | -$584.0K | $836.0K | -$420.0K | -$679.0K | -$1.1M | ||||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $57.0K | $9.0K | $57.0K | |||||||||||||||||||||
| Proceeds From Stock Plans | ||||||||||||||||||||||||
| Payments To Acquire Marketable Securities | $27.5M | $30.3M | $9.0M | |||||||||||||||||||||
| Depreciation Depletion And Amortization | $37.0K | $35.0K | $19.0K | $11.0K | ||||||||||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $17.6M | $22.2M | $18.0M | |||||||||||||||||||||
| Proceeds From At Market Sales Net Of Commissions | $4.2M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.32 | -$0.47 | -$0.29 | -$0.45 | -$1.49 | -$1.81 | -$2.28 | -$58.44 |
| Common Stock Shares Outstanding | 128.3M | 93.6M | 68.3M | 59.9M | 28.5M | 18.5M | 17.8M | 438.6K |
| Common Stock Shares Issued | 128.3M | 93.6M | 68.3M | 59.9M | 28.5M | 18.5M | 17.8M | 438.6K |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 101.9M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Shares Outstanding Basic | 134.7M | 102.0M | 99.0M | 64.5M | 22.8M | |||
| Earnings Per Share Basic | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 22.8M | 18.1M | 11.7M | 437.6K | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 134.7M | 102.0M | 99.0M | 64.5M | 22.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.08 | -$0.09 | -$0.09 | -$0.13 | -$0.12 | -$0.11 | -$0.08 | -$0.07 | -$0.06 | -$0.12 | -$0.14 | -$0.24 | -$0.34 | -$0.49 | -$0.43 | -$0.41 | -$0.41 | -$0.48 | -$0.41 | -$0.63 | -$13.85 | -$16.22 | -$13.62 | -$11.82 |
| Common Stock Shares Outstanding | 128.2M | 121.8M | 99.9M | 75.5M | 72.6M | 69.0M | 63.9M | 63.1M | 60.1M | 58.3M | 39.7M | 30.8M | 18.5M | 21.5M | 19.9M | 18.3M | 17.9M | 17.8M | 17.8M | 17.8M | 438.6K | |||
| Common Stock Shares Issued | 128.2M | 121.8M | 99.9M | 75.5M | 72.6M | 69.0M | 63.9M | 63.1M | 60.1M | 58.3M | 39.7M | 30.8M | 21.6M | 21.5M | 19.9M | 18.3M | 17.9M | 17.8M | 17.8M | 17.8M | 446.5K | |||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 101.9M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 145.1M | 130.4M | 117.6M | 101.3M | 101.0M | 99.5M | 99.3M | 98.7M | 98.6M | 68.9M | 59.5M | 30.8M | 21.6M | 20.1M | ||||||||||
| Earnings Per Share Basic | $-0.08 | $-0.09 | $-0.09 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.07 | $-0.06 | $-0.12 | $-0.14 | $-0.24 | $-0.34 | $-0.49 | ||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 30.8M | 21.6M | 20.1M | 19.4M | 18.1M | 17.8M | 17.8M | 17.8M | 10.6M | 444.1K | 438.6K | 438.6K | 434.6K | |||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 145.1M | 130.4M | 117.6M | 101.3M | 101.0M | 99.5M | 99.3M | 98.7M | 98.6M | 68.9M | 59.5M | 30.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.2M | $3.6M | $2.2M | $2.3M | $2.5M | $2.4M | $1.1M | $496.0K |
| Stock Issued During Period Value Stock Options Exercised | $2.1M | $394.0K | $74.0K | $139.0K | $34.0K | $38.0K | $13.0K | |
| Additional Paid In Capital | $512.8M | $386.5M | $321.6M | $317.6M | $198.0M | $174.2M | $168.7M | |
| Prepaid Expense Current | $1.3M | $939.0K | $3.6M | $795.0K | $886.0K | $1.0M | $1.7M | $1.4M |
| Stock Issued During Period Value Employee Stock Purchase Plan | $118.0K | $70.0K | $68.0K | $56.0K | $39.0K | $12.0K | ||
| Depreciation | $43.0K | $50.0K | $47.0K | $39.0K | $23.0K | |||
| Amortization Of Financing Costs And Discounts | $180.0K | $520.0K | $599.0K | $227.0K | $60.0K | |||
| Embedded Derivative Gain Loss On Embedded Derivative Net | -$147.0K | $82.0K | -$9.0K | |||||
| Stock Issued During Period Shares Stock Options Exercised | 851.6K | 262.0K | 146.1K | 51.0K | 18.3K | 14.7K | ||
| Stock Issued During Period Value New Issues | $107.4M | $46.8M | $7.1M | $3.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.2M | $1.4M | $1.2M | $822.0K | $1.1M | $723.0K | $530.0K | $606.0K | $578.0K | $569.0K | $520.0K | $737.0K | $540.0K | $745.0K | $718.0K | $588.0K | $589.0K | $730.0K | $371.0K | $237.0K | $146.0K | $121.0K | $102.0K | $88.0K |
| Stock Issued During Period Value Stock Options Exercised | $1.1M | $13.0K | $718.0K | $162.0K | $214.0K | $4.0K | $3.0K | $7.0K | $62.0K | $139.0K | $7.0K | $27.0K | $14.0K | $24.0K | $13.0K | |||||||||
| Additional Paid In Capital | $511.1M | $508.0M | $396.7M | $334.4M | $328.6M | $322.4M | $321.1M | $318.9M | $318.2M | $314.7M | $256.9M | $198.7M | $183.8M | $182.9M | $179.0M | $173.1M | $170.1M | $169.5M | $168.4M | $168.0M | ||||
| Prepaid Expense Current | $1.4M | $1.8M | $1.5M | $1.2M | $1.8M | $3.2M | $4.0M | $3.0M | $1.3M | $1.3M | $1.6M | $477.0K | $1.9M | $2.1M | $1.1M | $1.8M | $3.0M | $1.7M | ||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $59.0K | $34.0K | $33.0K | $23.0K | $17.0K | $3.0K | ||||||||||||||||||
| Depreciation | $11.0K | $13.0K | $10.0K | $9.0K | $2.0K | |||||||||||||||||||
| Amortization Of Financing Costs And Discounts | $81.0K | $154.0K | $145.0K | $43.0K | ||||||||||||||||||||
| Embedded Derivative Gain Loss On Embedded Derivative Net | -$136.0K | -$11.0K | -$5.0K | $40.0K | -$6.0K | |||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 290.3K | 2.6K | 122.0K | 7.9K | ||||||||||||||||||||
| Stock Issued During Period Value New Issues | $107.4M | $5.0K | -$22.0K | $359.0K | $2.7M | $4.1M | $2.4M |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.